SCHEMBL25404658

SCHEMBL25404658

NC(c1ccc(Cl)cc1)C12C3C4C5C3C1C5C42

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.43
IDO1 P14902 3/20 0.36
TDO2 P48775 3/20 0.36
TSHR P16473 2/20 0.35
MAPK1 P28482 2/20 0.35
HIF1A Q16665 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
LMNA P02545 2/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
CYP19A1 P11511 3/20 0.34
SLC6A4 P31645 2/20 0.33
BRD4 O60885 1/20 0.33
SLC6A3 Q01959 2/20 0.32
CYP2A6 P11509 1/20 0.32
CYP2D6 P10635 2/20 0.32
MEN1 O00255 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1732927 0.65 ADRB2 (0.62) ADRB2IDO1TDO2TSHRMAPK1
SCHEMBL1155851 0.65 ADRB2 (0.62) ADRB2IDO1TDO2TSHRMAPK1
SCHEMBL3678300 0.65 ADRB2 (0.62) ADRB2IDO1TDO2TSHRMAPK1
SCHEMBL24017052 0.65 ADRB2 (0.62) ADRB2IDO1TDO2TSHRMAPK1
SCHEMBL3253726 0.65 ADRB2 (0.62) ADRB2IDO1TDO2TSHRMAPK1
SCHEMBL3834022 0.64 SLC6A4 (0.44) ADRB2IDO1TDO2TSHRMAPK1
Hydrochloric Acid SCHEMBL3179658 0.63 ADRB2 (0.59) ADRB2IDO1TDO2TSHRMAPK1
Hydrochloric Acid SCHEMBL30098243 0.63 ADRB2 (0.59) ADRB2IDO1TDO2TSHRMAPK1
SCHEMBL29155404 0.63 ADRB2 (0.59) ADRB2IDO1TDO2TSHRMAPK1
SCHEMBL18527097 0.63 IDO1 (0.44) ADRB2IDO1TDO2TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12516046-B2 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors MERCK SHARP & DOHME LLC (US) 2026-01-06 US disclosed
US-20230227441-A1 2-OXO-OXAZOLIDINE-5-CARBOXAMIDES AS NAV1.8 INHIBITORS MERCK SHARP & DOHME LLC (US) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227441-A1 2-OXO-OXAZOLIDINE-5-CARBOXAMIDES AS NAV1.8 INHIBITORS SCN8A, TRPV1, SCN2A ADRB2 476/4885IDO1 1192/4885TDO2 4046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.